Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-26-063223
Filing Date
2026-05-18
Accepted
2026-05-18 16:27:00
Documents
15
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm266546-1_def14a.htm   iXBRL DEF 14A 748041
4 GRAPHIC lg_alumis-4c.jpg GRAPHIC 9028
5 GRAPHIC px_26alumispy1pg01-bw.jpg GRAPHIC 238018
6 GRAPHIC px_26alumispy1pg02-bw.jpg GRAPHIC 205664
  Complete submission text file 0001104659-26-063223.txt   2178022

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA alms-20251231.xsd EX-101.SCH 6608
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE alms-20251231_lab.xml EX-101.LAB 22770
18 EXTRACTED XBRL INSTANCE DOCUMENT tm266546-1_def14a_htm.xml XML 5720
Mailing Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 650-231-6625
ALUMIS INC. (Filer) CIK: 0001847367 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-42143 | Film No.: 26993901
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)